AMG 701 Expanded Access Program

Amgen

Status

Treatments: Drug: AMG 701

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT05256446

AMG701 Expanded Access Program

Details and patient eligibility

About

Expanded access requests for AMG 701 may be considered for adult patients with relapsed and/or refractory multiple myeloma whose disease is in partial response or better after AMG 420 therapy. To request access, use Responsible Party contact information provided in this record.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria